Figure 1

Univariate marginal estimates for change in predicted probability of participation of parents; highest and lowest value for attributes versus base-case. The base-case is an HPV vaccination at age 12 years, 1/150,000 risk of serious side-effects, duration of protection of 6 years, and 70% degree of protection against cervical cancer. This base-case is indicated as zero change in the probability of the x-axis. Assuming our base-case, the expected uptake was 63.3%